Survival outcome after surgery in patients with thymoma distant recurrence

Gynecologic Cancer

Survival outcomes comparing minimally invasive versus open cytoreductive surgery in recurrent adult-type granulosa cell tumors

Am J Obstet Gynecol

Brodsky AL, Legarreta AF, How JA, Vuttaradhi V, Sood AK, Ramondetta LM, Gershenson DM, Hillman RT

doi: 10.1016/j.ajog.2025.01.012

Skin Cancer

Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis

Lancet Oncol

Stassen RC, Maas CCHM, van der Veldt AAM, Lo SN, Saw RPM, Varey AHR, Scolyer RA, Long GV, Thompson JF, Rutkowski P, Keilholz U, van Akkooi ACJ, Verhoef C, van Klaveren D, Grünhagen DJ

doi: 10.1016/S1470-2045(24)00076-7

Head and Neck Cancer

Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer

Oral Oncol

Krc R, Mendes W, Molitoris J, Ferris M, Song Y, Shetty A, Mehra R, Papadimitriou JC, Hatten K, Taylor R, Wolf J, Sun K, Bentzen S, Regine W, Tran P, Witek M

doi: 10.1016/j.oraloncology.2024.106875

Breast Cancer

21-Gene Recurrence Score and Survival Outcomes in the Phase III Multicenter TAILORx Clinical Trial

J Natl Compr Canc Netw

Yang SX, Yu J, Wang M

doi: 10.6004/jnccn.2024.7008

Further Publications

Trajectories of patient-reported outcomes after oesophageal cancer surgery - A population-based study

Eur J Cancer

Färnqvist K, Mälberg K, Johar A, Schandl A, Lagergren P

doi: 10.1016/j.ejca.2024.114133

Gastrointestinal Cancer

Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY

J Clin Oncol

Kang YK, Kim HD, Yook JH, Park YK, Lee JS, Kim YW, Kim JY, Ryu MH, Rha SY, Chung IJ, Kim IH, Oh SC, Park YS, Cheong JH, Jeong O, Heo MH, Kim HK, Park C, Yoo CH, Kang SY, Zang DY, Jang YJ, Sul JY, Kim JG, Kim BS, Beom SH, Hwang JE, Ryu SW, Kook MC, Ryoo BY, Kim H, Yoo MW, Lee NS, Lee SH, Noh SH

doi: 10.1200/JCO.23.02167

Skin Cancer

Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator

J Clin Oncol

Varey AHR, Li I, El Sharouni MA, Simon J, Dedeilia A, Ch'ng S, Saw RPM, Spillane AJ, Shannon KF, Pennington TE, Rtshiladze M, Stretch JR, Nieweg OE, van Akkooi A, Sullivan RJ, Boland GM, Gershenwald JE, van Diest PJ, Scolyer RA, Long GV, Thompson JF, Lo SN

doi: 10.1200/JCO.23.01020

Breast Cancer

Clinical and patient-reported outcomes after oncoplastic versus conventional breast conserving surgery-a longitudinal, multicenter cohort study

J Natl Cancer Inst

Bargon CA, Mink Van Der Molen DR, Young-Afat DA, Batenburg MCT, Van Dam IE, Baas IO, Ernst MF, Maarse W, Sier MF, Schoenmaeckers EJP, Burgmans JPJ, Bijlsma RM, Siesling S, Rakhorst HA, Mureau MA, Van Der Leij F, Doeksen A, Verkooijen HM, UMBRELLA Study Group

doi: 10.1093/jnci/djae310

Lung, Respiratory and Thoracic Cancer

Clinical characteristic and survival outcomes of patients with advanced NSCLC according to KRAS mutational status in the French real-life ESME cohort

ESMO Open

Thomas QD, Quantin X, Lemercier P, Chouaid C, Schneider S, Filleron T, Remon-Masip J, Perol M, Debieuvre D, Audigier-Valette C, Justeau G, Loeb A, Hiret S, Clement-Duchene C, Dansin E, Stancu A, Pichon E, Bosquet L, Girard N, Du Rusquec P

doi: 10.1016/j.esmoop.2024.103473

Related content